# Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity

> **NCT02664441** · PHASE3 · COMPLETED · sponsor: **Seattle Children's Hospital** · enrollment: 42 (actual)

## Conditions studied

- Hypothalamic Obesity

## Interventions

- **DRUG:** Exenatide
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02664441
- **Lead sponsor:** Seattle Children's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-03
- **Primary completion:** 2020-03-16
- **Final completion:** 2020-07-31
- **Target enrollment:** 42 (ACTUAL)
- **Last updated:** 2022-05-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02664441

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02664441, "Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02664441. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*